EX-10.1 2 d652710dex101.htm EX-10.1 Execution Version EMPLOYMENT AGREEMENT
Exhibit 10.1
Execution Version
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of November 13, 2018 by and between TransUnion, a Delaware corporation (together with its successors and assigns, the “Company”), and Xxxxxxxxxxx X. Xxxxxxxxxx (“Executive” and, together with the Company, the “Parties” and each a “Party”).
| 1. |
serving on outside boards or committees) without the consent of the Board, provided that Executive shall be permitted to (i) manage Executive’s personal, financial and legal affairs, (ii) participate in trade associations, (iii) serve on the board of directors of not-for-profit or tax-exempt charitable organizations, and (iv) subject to approval by the Board, serve on the board of directors or similar board of for-profit organizations, in each case, subject to compliance with this Agreement and provided that such activities do not materially interfere with Executive’s performance of Executive’s duties and responsibilities hereunder and are not otherwise considered to be inappropriate by the Board. Executive agrees to observe and comply with the rules and policies of the Company and its subsidiaries as adopted by the Company or its Affiliates from time to time, in each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a “Policy”).
(f) Principal Place of Employment. Executive’s principal office shall be the Company’s headquarters in Chicago, Illinois. The Parties understand that given the nature of Executive’s duties, Executive will be required to travel and perform services at locations other than his principal office from time to time.
| 2. |
2
following the Effective Date. During the Term, the Annual Bonus shall be based upon the achievement of the applicable Company and/or individual performance metrics as pre-established by the Committee with the maximum amount payable up to 200% of the target amount. Executive’s goals, objectives and performance targets will be developed by the Committee on an annual, ongoing basis, provided that in no event will Executive’s bonus targets be less than the Target Bonus during the Term.
(c) Long-Term Incentives.
(i) Initial Equity Grant. On or as soon reasonably practicable following the Effective Date, the Company will grant Executive an additional equity incentive award under the Transunion 2015 Omnibus Incentive Plan, as amended from time to time (the “Incentive Plan”), containing the same terms and conditions as the 2019 annual equity incentive award under the Incentive Plan made to executives of the Company generally, in an amount whereby the total target grant date fair value for all equity incentive awards granted during the entire 2019 calendar year to the Executive totals $5.5 million (the “Initial Equity Grant”).
(ii) Future Equity Grants. Beginning in calendar year 2020, the Company will grant Executive equity incentive awards under the Incentive Plan for each calendar year of the Company commencing during the Term in an amount as determined by the Committee (together with the Initial Equity Grant, the “LTI Grants”).
(iii) Award Terms. The type of award and specific terms and conditions of the LTI Grants will be determined by the Committee, but shall be commensurate with Executive’s position and the terms shall be consistent with the terms applicable to other executives of the Company.
3
Executive’s execution of applicable undertakings, as provided by such corporate documents or applicable law, both during Executive’s employment and thereafter, with regard to Executive’s actions or inactions in connection with being an officer or director of the Company or any of its Affiliates and the Company shall enter into an indemnification agreement with Executive in the form of its standard indemnification agreement with its directors. Both during Executive’s employment and, thereafter, while potential liability exists, with regard to Executive’s prior activities as an officer or director the Company shall also provide Executive with director and officer liability insurance coverage on the same basis, if any, such coverage is provided to similarly situated officers and directors of the Company.
| 3. |
(i) Death. Executive’s employment hereunder shall terminate upon Executive’s death.
(iii) Termination for Cause. The Company may terminate Executive’s employment for Cause.
(iv) Termination without Cause. The Company may terminate Executive’s employment without Cause.
4
that occurs on or following the date of the Company’s receipt of such Notice of Termination and is prior to the date specified in such Notice of Termination. A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination, or any date thereafter elected by the Company in its sole discretion (subject to any Executive cure rights in the case of a termination for Cause pursuant to Section 3(a)(iii)). In the event of a dispute over the existence of Cause or Good Reason, either Party may introduce newly discovered or newly arising evidence in support of or in opposition to the determination of Cause or Good Reason.
| 4. |
5
below), and not revoking, a release of claims substantially in the form attached hereto as Exhibit A (which form the Company may revise to reflect changes in applicable law if such changes are reasonably necessary in order for the Company to obtain a valid release of claims in favor of the Company and its Affiliates (the “Release”)), and Executive’s continued compliance with Section 5 and Section 6 and all applicable Policies (other than non-compliance that is de minimis and inconsequential or inadvertent and cured within five (5) business days of notice thereof from the Company), Executive shall receive, in addition to payments and benefits set forth in Section 3(c), the following benefits (the “Termination Payments”):
(i) a cash payment in an amount equal to two (2) times the sum of the Base Salary and the Target Bonus payable over eighteen (18) months immediately following the Date of Termination in equal installments in accordance with the Company’s regular payroll practices following the Date of Termination;
(ii) if the Date of Termination occurs on or after July 1 in a given calendar year, an amount equal to a pro rata portion of the Target Bonus;
(iii) a lump sum amount equal to the Company’s estimate of the premiums under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) for the 18-month period following the Date of Termination if Executive, for Executive and Executive’s eligible dependents, continued on COBRA for such period;
(iv) the services of an outplacement agency of Executive’s choosing for a period of up to one year and with a maximum value of $50,000, provided that any payments pursuant to this Section 4(b)(iv) shall be made directly to the outplacement firm for services rendered upon receipt of satisfactory documentation;
(v) if the Date of Termination occurs on or after October 1 in a given calendar year, an amount equal to the Company’s 401(k) retirement contribution that Executive would have received for the year in which the Date of Termination occurs if Executive had remained employed through the last working day of that year; and
(vi) any equity incentive compensation award granted Executive on or after January 1, 2019 shall pro-rata vest based on the number of full and partial months actively employed during either the vesting period or performance period, as applicable, whereby (A) in the case of any award with a service-vesting component only starting with the date of grant of the award and ending with the Date of Termination and (B) in the case of any award with a performance-vesting component starting with the date of the beginning of the applicable performance period and ending with the earlier of the Date of Termination or the last day of the performance period. Any award with a service-vesting component only shall vest effective as if the Date of Termination was the last day of the service-vesting period and any award with a performance-vesting component shall remain subject to actual performance attainment during the full performance period with the payment of any such performance award otherwise made at such time and under such other circumstances as would have applied without regard to Executive’s employment termination.
6
Subject to execution and nonrevocation of the Release, the cash lump sum amounts payable pursuant to Section 4(b)(ii), (iii) and (v) shall be paid sixty (60) days after Executive’s Date of Termination. Executive agrees that in the event Executive materially breaches any of the Restrictive Covenants (as defined below), Executive shall be required to immediately repay the full amount of the Termination Payments, which repayment shall be in addition to, and not in lieu of, all other legal and equitable remedies available to the Company, and Executive agrees further that if Executive contests any nonpayment of Termination Payments based on non-compliance with Section 5 or Section 6 or any Policy which Executive claims is de minimis and inconsequential or inadvertent and cured within five (5) business days of notice thereof from the Company, all Termination Payments will be tolled until final resolution of the matter. For the purposes of clause (ii) above, “pro rata” means a fraction, the numerator of which is the number of days in the calendar year that have elapsed to, and including, termination, and the denominator of which is 365.
| 5. |
(a) Executive acknowledges and agrees that the Company has expended and will expend substantial time, effort and resources in developing and maintaining its “Confidential Information and Trade Secrets,” as that phrase is defined in the “Executive’s Agreement Regarding Inventions, Confidential Information and Trade Secrets” (the “Confidentiality Agreement”), which is attached hereto as Exhibit B and which is fully incorporated herein. Executive therefore agrees that, contemporaneously with Executive’s execution of this Agreement, Executive also will execute the Confidentiality Agreement and shall comply with all the terms and conditions thereof.
(b) Executive covenants and agrees that during the Term and for a period of twelve (12) months thereafter (the Term and such period, collectively, the “Restricted Period”), Executive shall not, except as expressly permitted by this Agreement, directly or indirectly own an interest in, operate, join, control, advise, work for, consult to, have a financial interest which provides any control of, or participate in, any Competitor. This prohibition applies anywhere within North America, including Canada, the United States of America and Mexico, the United Kingdom, the Republic of South Africa, Hong Kong, Brazil and any other country in which, on the Date of Termination of Executive’s employment, the Company has operations that generate revenues that are at least equal to the revenues generated by the Company’s operations in any of the countries set forth in this sentence. This covenant does not prohibit the mere ownership of less than one percent (1%) of the outstanding stock of any publicly-traded corporation as long as Executive does not actually control such corporation and are not otherwise in violation of this Agreement.
7
(c) Executive covenants and agrees that, at all times during the Restricted Period, Executive shall not except as expressly permitted by this Agreement, directly or indirectly, on Executive’s own behalf or on behalf of any other Person, contact, solicit, induce or recruit any Customer to acquire any Competitive Product or Service from any Person other than the Company or its Affiliates.
(d) Executive covenants and agrees that, at all times during the Restricted Period, Executive shall not receive commissions, agency fees, or compensation of any kind directly based on sales of any Competitive Product or Service to any Customer or otherwise relating to the placement, negotiation or transfer of any Competitive Product or Service with or to any Customer. Notwithstanding the foregoing however, this provision shall not restrict or prohibit Executive from selecting any Competitive Product or Service in a capacity as an officer or director of any Person, including any Customer.
(e) Executive agrees that the Company has invested and will invest substantial time and effort in acquiring and maintaining its workforce. Accordingly, Executive agrees that during the Term and for a period of twenty-four (24) months thereafter, Executive shall not, nor cause any other Person to, (i) hire away any individual who was employed by the Company or any of its Affiliates at any time on or after that date which is six (6) months prior to Executive’s termination of employment, or (ii) directly or indirectly, entice, solicit or seek to induce or influence any such individual to leave their employment with the Company or any of its Affiliates. Notwithstanding the foregoing, the restrictions set forth in this Section 5(e) shall cease to apply with respect to any individual (other than Executive) upon such individual’s ceasing to be employed by the Company or any of its Affiliates for a period of six (6) consecutive months.
(f) Executive covenants and agrees that, at all times during the Restricted Period, Executive shall not, except as expressly permitted by this Agreement, divert or attempt to divert or take advantage of or attempt to take advantage of any actual or potential business or opportunities of the Company or any of its subsidiaries, of which Executive became aware as the result of Executive’s employment with the Company and which relate specifically to the Business, or any part thereof, as conducted or, to Executive’s knowledge, planned to be conducted, as of the Date of Termination of Executive’s employment with the Company or at any time within the 12-month period immediately preceding the Date of Termination or the date of such conduct (if Executive is then employed by the Company).
(g) Executive acknowledges that should Executive violate any of the covenants contained in this Section 5 or in Section 6 (collectively, the “Restrictive Covenants”), it will be difficult to determine the resulting damages to the Company and its Affiliates and, in addition to any other remedies the Company and its Affiliates may have, the Company and its Affiliates shall be entitled to temporary injunctive relief without being required to post a bond and permanent injunctive relief without the necessity of proving actual damage. The Company may elect to seek one or more of these remedies at its sole discretion on a case-by-case basis. Failure to seek any or all remedies in one case shall not restrict the Company from seeking any remedies in another situation. Such action by the Company shall not constitute a waiver of any of its rights.
8
(h) It is the Parties’ intent that each of the Restrictive Covenants be read and interpreted with every reasonable inference given to its enforceability. However, it is also the Parties’ intent that if any term, provision or condition of the Restrictive Covenants is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the provisions thereof shall remain in full force and effect and shall in no way be affected, impaired or invalidated. Finally, it is also the Parties’ intent that if a court should determine any of the Restrictive Covenants are unenforceable because of over-breadth, then the court shall modify said covenant so as to make it reasonable and enforceable under the prevailing circumstances.
(i) In the event of any material breach by Executive of any Restrictive Covenant, the running of the period of restriction shall be automatically tolled and suspended for the duration of such breach, and shall automatically recommence when such breach is remedied in order that the Company shall receive the full benefit of Executive’s compliance with each of the Restrictive Covenants.
(j) Executive agree that the Restrictive Covenants shall be enforced independently of any other obligations between the Company, on the one hand, and Executive, on the other (other than the Company’s obligation to make payments hereunder), and that the existence of any other claim or defense shall not affect the enforceability of the Restrictive Covenants or the remedies provided herein.
(k) Pursuant to 18 U.S.C. § 1833(b), Executive understands that Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret of the Company that (i) is made (A) in confidence to a Federal, State, or local government official, either directly or indirectly, or to Executive’s attorney and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Executive understands that if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney and use the trade secret information in the court proceeding if Executive (x) files any document containing the trade secret under seal, and (y) does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement, or any other agreement that Executive has with the Company, is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. Further, nothing in this Agreement or any other agreement that Executive has with the Company shall prohibit or restrict Executive from making any voluntary disclosure of information or documents concerning possible violations of law to any governmental agency or legislative body, or any self-regulatory organization, in each case, without advance notice to the Company.
| 6. |
(a) Executive shall not, directly or indirectly, except to the extent otherwise required to enforce rights of Executive against the Company, disparage the Company and/or communicate, either in writing or orally, any statement that bears negatively on the Company’s reputation, services, products, principals, customers, policies, adherence to the law (unless otherwise required by law), shareholders, officers, directors, officials, executives, employees, agents, representatives, business or other legitimate interests of the Company.
9
(b) The Company agrees that, except to the extent otherwise required to enforce rights of the Company against Executive, upon Executive’s termination of employment it shall instruct its directors and senior officers not to make any disparaging remarks about Executive for so long as such persons remain directors and/or senior officers of the Company, provided that nothing in this Section 6(b) shall prevent the Company or such persons from providing truthful testimony before, or statements to, any governmental agency, legislative body, or any self-regulatory organization.
(b) During the 12-month period following the termination of Executive’s employment with the Company for any reason, Executive will provide reasonable assistance to and shall cooperate with the Company and its Affiliates in connection therewith, upon the Company’s reasonable request, regarding matters within the scope of Executive’s duties and responsibilities during Executive’s employment of which Executive have particular knowledge; provided that, the Company shall make reasonable best efforts to minimize disruption of Executive’s other activities. Any expenses reasonably incurred by Executive in connection with such assistance shall be reimbursed by the Company.
10
10. Certain Definitions. For purposes of this Agreement:
(a) Business means the business conducted or planned to be conducted by the Company and its Affiliates as of a specified date. As of the date of this Agreement, the Business includes the automated collection of personalized data relating to consumers and the automated delivery of credit, collection, identity, fraud, verification (insurance coverage or ability for public assistance), or risk management products and services for businesses operating in the financial services, insurance, health care or telecommunications industries, or directly to consumers over the internet.
(b) Cause means any of the following as determined by the Board in its good faith discretion: (i) a material breach by Executive of the terms of this Agreement or a Policy; (ii) Executive’s willful failure or refusal to perform his material duties hereunder; (iii) the disregard of the legal directives of the Board which are not inconsistent with the scope, ethics and nature of Executive’s duties and responsibilities hereunder; (iv) engaging in misconduct that has, or could reasonably be expected to have, a material and adverse impact on the reputation, business, business relationships or financial condition of the Company or any of its Affiliates; (v) the commission of an act of fraud or embezzlement or acts of personal dishonesty involving personal profit against the Company or any of its Affiliates; or (vi) any commission of acts constituting, any conviction of, or plea of guilty or nolo contendere to, a felony or a crime involving fraud or misrepresentation, or other crime that results, or could reasonably be expected to result, in material harm to the reputation, business, business relationships or financial condition of the Company or any of its Affiliates; provided that Cause shall not be deemed to exist under any of the foregoing clauses (i), (ii) or (iii) unless Executive has been given reasonably detailed written notice of the grounds for such Cause and, if curable, Executive has not effected a cure within twenty (20) days after the date of receipt of such notice.
11
(c) Competitive Product or Service means any product or service which is competitive with any product or service provided by the Company or any of its Affiliates in connection with the Business, as conducted or, to Executive’s knowledge, planned to be conducted, as of the Date of Termination or at any time within the 12-month period immediately preceding the Date of Termination or the date of such conduct (if Executive is then employed by the Company).
(d) Competitor means the operating unit or business segment of any other Person that has Significant Operations that are competitive with, or in substantially the same line of business as, the Business, which for the avoidance of doubt as of the date hereof includes without limitation any of the following companies (including any of their successors, assigns or Affiliates): Acxiom Corporation, CBC Companies, CSC Credit Services, The Dun & Bradstreet Corporation, Equifax, Inc., Experian Group Limited, Fair Xxxxx Corporation, Fidelity National Information Services, Inc., The First American Corporation (Corelogic), Innovis Data Solutions, Inc., InfoUSA, Inc., RELX PLC and Verisk Analytics.
(e) Customer means any Person or entity to which the Company or any of its Affiliates has provided, or actively solicited, the sale of products or services in the twelve (12) months prior to the Date of Termination.
(f) Date of Termination means (i) if Executive’s employment is terminated by Executive’s death, the date of Executive’s death; (ii) if Executive’s employment is terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 3(b), whichever is earlier.
(g) Disability means any event that results in Executive’s eligibility to receive benefits under the Company’s disability insurance policies, as in effect from time to time; provided, however, that if the Company does not maintain disability insurance, “Disability” shall mean Executive’s inability to perform substantially all of Executive’s duties and responsibilities to the Company by reason of a physical or mental disability or infirmity for either (i) a continuous period of three months or (ii) 180 days (which need not be continuous) during any consecutive 12-month period. The date of such Disability will be (x) in the case of clause (i) above the last day of such three-month period or, if later, the day on which satisfactory medical evidence of such Permanent Disability is obtained by the Company, or (y) in the case of clause (ii) above, such date as is determined in good faith by the Board. In the event that any disagreement or dispute arises between Executive and the Company as to whether Executive has incurred a Disability, then, in any such event, Executive will submit to a physical and/or mental examination by a competent, qualified and duly licensed physician who will be mutually selected by Executive and the Company, and such physician will make the determination of whether Executive suffers from any disability. In the absence of fraud or bad faith, the determination of such physician will be final and binding upon both Executive and the Company. The cost of any such examination will be paid by the Company.
(h) Good Reason means the occurrence, without Executive’s consent, of any of the following events: (i) a material reduction in position, overall responsibilities, level of authority, title or level of reporting; (ii) a material reduction in Executive’s Base Salary and Annual Bonus compensation opportunity, measured in the aggregate, which is not the result of a uniformly
12
applied adjustment across all executives within the Company; (iii) a requirement that Executive’s location of employment be relocated by more than fifty (50) miles from Executive’s then-current location or (iv) a material breach by the Company of any material written agreement with Executive; provided that Executive must (x) provide written notice to the Company within ninety (90) calendar days following the occurrence of an event that Executive considers to constitute Good Reason (stating in reasonable detail the nature of the event giving rise thereto), (y) provide the Company thirty (30) days to cure the Good Reason, and, (z) if the Good Reason is not cured, end Executive’s employment with the Company within ninety (90) calendar days following such event.
(i) Person means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, or a governmental entity (or any department, agency, or political subdivision thereof).
(j) Significant Operations means a business that generates revenues that equal or exceed twenty percent (20%) of the Company’s consolidated revenues as of the end of the immediately preceding calendar year.
(a) Governing Law. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of Illinois without reference to the principles of conflicts of law thereof or any other jurisdiction, and where applicable, the laws of the United States.
(b) AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER HAVING THE OPPORTUNITY TO CONSULT WITH LEGAL COUNSEL), THE COMPANY AND EXECUTIVE EACH EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY.
(c) Survival. Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 4 through 9 and this 11 will survive the termination of Executive’s employment and the expiration or termination of the Term.
(i) If to the Company, to the attention of its Chief Legal Officer at its headquarters,
(ii) If to Executive, at the last address that the Company has in its personnel records for Executive, or
13
(iii) At any other address as any Party shall have specified by notice in writing to the other Party.
14
(ii) Separation from Service. Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s “separation from service” with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as provided below, any such compensation or benefits described in Section 4 shall not be paid, or, in the case of installments, shall not commence payment, until the sixtieth (60th) day following Executive’s Separation from Service (the “First Payment Date”). Any lump sum payment or installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s Separation from Service but for the preceding sentence shall be paid to Executive on the First Payment Date and any remaining installment payments shall be made as provided in this Agreement.
15
(iv) Expense Reimbursements. To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred, provided that Executive must submit Executive’s reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.
[Signature Page Follows]
16
| TRANSUNION | ||
| By: | /s/ XXX X. XXXXXX | |
| Name: | Xxx X. Xxxxxx | |
| Title: | Chairman, Board of Directors | |
| By: | /s/ XXXXXXX X. XXXXX | |
| Name: | Xxxxxxx X. Xxxxx | |
| Title: | Senior Vice President, Corporate Secretary | |
| EXECUTIVE | ||
| /s/ XXXXXXXXXXX X. XXXXXXXXXX | ||
| Xxxxxxxxxxx X. Xxxxxxxxxx |
[Signature Page to Employment Agreement]
Exhibit A
RELEASE OF CLAIMS
This General Release of Claims (this “Release”) by Xxxxxxxxxxx X. Xxxxxxxxxx (“Executive”) is attached to the Employment Agreement, by and among TransUnion, a Delaware corporation (together with its successors and assigns, the “Company”), and Executive, dated as of November 13, 2018 (the “Agreement”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Agreement.
(a) Executive, on behalf of Executive and Executive’s heirs, executors, administrators, successors and assigns, hereby irrevocably and unconditionally releases the Releasees (as defined in Section 1(c) below) from any and all claims, liabilities, causes of action, rights, complaints, sums of money, suits, debts, covenants, contracts, agreements, promises, benefits, obligations, damages, demands or liabilities of every nature, kind and description, in law, equity or otherwise, whether known or unknown, suspected or unsuspected (collectively, “Claims”) which Executive or Executive’s heirs, executors, administrators, successors or assigns ever had, now has or may hereafter claim to have by reason of any matter, cause or thing whatsoever: (i) arising from the beginning of time through the date upon which Executive signs this Release including, but not limited to, any such Claims relating in any way to Executive’s employment with the Company or any of the other Releasees, and any such Claims arising under any federal, state, local or foreign statute or regulation or common law, including without limitation the Age Discrimination in Employment Act (ADEA), that may be legally waived and released; (ii) arising out of or relating to the termination of Executive’s employment with the Company or any of the other Releasees; or (iii) arising under or relating to any policy, agreement, plan, understanding or promise, written or oral, formal or informal, between the Company or any of the other Releasees and Executive. It is further understood and agreed that, notwithstanding any statute or common law principle, and for the purpose of implementing a full and complete release and discharge of all claims, Executive expressly acknowledges that this Release is intended to include in its effect, without limitation, all Claims which Executive does not know or suspect to exist in Executive’s favor at the time of execution hereof, and that the release agreed upon herein contemplates the full extinguishment of Executive’s Claims.
(b) Notwithstanding the foregoing, the Company and Executive recognize that nothing contained in this Section 1 shall in any way release or discharge: (i) Executive’s right to bring any Claim that cannot be waived under applicable law; (ii) Executive’s right to enforce, or bring any Claim for breach of, the Employment Agreement; (iii) Executive’s right to any vested benefits to which Executive may be entitled under any retirement, pension or any equity incentive compensation plan of the Company or its subsidiaries; or (iv) Executive’s right to bring any Claim for indemnification under any applicable directors and officers liability insurance policy or applicable state or federal law, as applicable (the “Excluded Claims”).
(c) For purposes of this Release, “Releasees” shall mean (i) the Company and all other members of the Company Group, and all of their respective predecessors, successors and assigns, and (ii) all past and present owners, investors, shareholders, trustees, directors, officers, partners, members, employees, agents, attorneys and representatives of each of the entities referenced in this Section 1(c) and each of their respective predecessors, successors, estates, heirs and assigns.
(a) Nothing in this Release prevents Executive from filing a charge with, or participating in any investigation or proceeding conducted by, the Equal Employment Opportunity Commission or any comparable federal, state or local government agency.
(b) Nothing in this Release prevents Executive from reporting possible violations of law or regulations to any governmental agency or legislative body, or any self-regulatory organization, or making other disclosures that are protected under the whistleblower provisions of federal, state or local law or regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and Executive is not required to notify the Company that Executive has made such reports or disclosures.
4. Period of Review and Revocation Rights.
(a) Executive understands and agrees that Executive has [twenty-one (21)] [forty-five (45)]* following Executive’s receipt of this Release to review this Release and its terms and to reflect upon them and consider whether Executive wants to sign it, although Executive may sign it sooner. Executive agrees that any modifications, material or otherwise, made to the Agreement after the date the Company provided this Release to Executive do not restart or affect in any manner the original [twenty-one (21)] [forty-five (45)] day consideration period. Executive understands and agrees that Executive may accept this Release by signing and returning it within the applicable time frame to [NAME], [TITLE], TransUnion at [MAILING ADDRESS].
| * | Executive is entitled to 45 days to review this Release in the event of a “group termination,” which means an “exit incentive program” or an “other employment termination program” offered to two or more individuals, each as defined in 29 C.F.R. § 1625.22(f)(1)(iii) and 21 days in the event of an individual termination. If this Release is being offered to Executive in connection with a group termination, Executive will also be provided with a listing of the ages and job titles of persons who were selected for the termination program and persons in the same decisional unit who were not selected for the termination program. |
2
(b) Executive further acknowledges that Executive will have seven (7) calendar days following Executive’s execution of this Release within which to revoke the terms of this Release. If Executive chooses to revoke his consent to this Release, the revocation must be in writing and delivered to [NAME], [TITLE], TransUnion at the address above no later than seven (7) calendar days after Executive has signed this Release. In the event of such revocation by Executive, this Release shall be null and void in its entirety, and, where applicable, Executive will not receive the Termination Payments. Provided that Executive does not revoke this Release, this Release shall become effective on the eighth (8th) calendar day following the date of Executive’s execution of this Release.
* * *
IN WITNESS WHEREOF, Executive has executed this Release on the date set forth below.
| Xxxxxxxxxxx X. Xxxxxxxxxx | ||||||
| Date Executed: | ||||||
| (Signature) |
3
Exhibit B
EXECUTIVE’S AGREEMENT REGARDING
INVENTIONS, CONFIDENTIAL INFORMATION AND TRADE SECRETS
In consideration for my employment or continued employment after this date by TransUnion, a Delaware corporation, and/or its affiliates, (collectively, the “Company”), I agree as follows:
1. I understand that the phrase “Confidential Information and Trade Secrets” includes, but is not limited to, the following either developed, created or licensed by, belonging to, or in the possession of the Company: (i) Inventions, (as that term is defined below) including all features of any Inventions, whether developed by me or the Company, or the Company’s affiliates, not yet patented or published, but subject to Paragraph 8 below; (ii) computer source code, and research and development data; (iii) business information such as information regarding the Company’s operations, product costs, vendor and customer lists, lists of approved components and sources, unpublished price lists, production schedules, business and marketing plans, technical plans, sales figures and all other financial and business information not yet publicly announced or publicly disclosed; (iv) any other information pertaining to the Company and its affiliates not generally available to the public or to competitors of the Company or its affiliates which, if disclosed, would materially damage the Company or its affiliates or would aid or benefit a competitor; (v) any information obtained by the Company, or its affiliates, under an obligation of confidentiality, from third parties, whether such Company or affiliate obligations are pursuant to a non-disclosure or confidentiality agreement or otherwise; and (vi) consumer information, including, but not limited to, consumer credit information and non-public personal information such as information pertaining to Company employees, customers, or other third persons.
2. I understand that the term “Inventions” shall mean all copyrights, patents, trademarks, service marks, trade names, moral rights, and all other intellectual property rights associated with any and all ideas, concepts, inventions, Confidential Information and Trade Secrets, discoveries, improvements, processes, methods, designs and works of authorship that relate to the Company’s existing, past, or proposed business, products, services, research and development, or any anticipated research and development, which were, or will be, made by me, either solely or jointly with others, during any past or future period of employment with the Company, except as provided in Paragraph 8 below. I understand that, for the purposes of this Agreement Regarding Inventions, Confidential Information and Trade Secrets (this “Inventions Agreement”), except as provided in Paragraph 8 below, Inventions shall be considered to have been made during my employment with the Company if they were conceived, in whole or in part, refined, developed or first practiced during my employment with the Company. However, I understand that this Inventions Agreement does not apply to any Inventions fully conceived, developed and reduced to practice after the termination of my employment with the Company and assigned to another company in accordance with an employment agreement with that second company.
Executive’s initials /s/ CC
3. I recognize that, except as provided in Paragraph 8 below, all records and copies of records concerning Inventions and Confidential Information and Trade Secrets made or received by me during my period of employment with the Company are the property of the Company exclusively and all such records are also deemed Confidential Information and Trade Secrets. I shall immediately surrender to the Company all such records or copies of records if and when my employment is terminated, or at any time during my employment at the Company’s request.
4. I understand and agree that I shall not disclose any Inventions or Confidential Information and Trade Secrets to any other person, firm, association or corporation except as required in the fulfillment of my duties and responsibilities in my employment with the Company as such duties and responsibilities have been explicitly authorized by the Company. I also agree that I shall not use any Inventions or Confidential Information and Trade Secrets for the private benefit of myself or for the benefit of any other person, firm, association or corporation.
5. I agree that during my employment with the Company all Inventions, discoveries and improvements, whether patentable or unpatentable, and all works of authorship, whether copyrightable or uncopyrightable, made, developed, conceived, modified, acquired, devised, discovered or created by me, whether alone or jointly with others, whether by using the Company’s or its divisions’ or affiliates’ equipment, supplies, facilities, or Trade Secrets or Confidential Information or otherwise, and which relate to or pertain in any way, at the time of conception or reduction to practice of the Invention or of creation of the work of authorship to the business of the Company, or its divisions or affiliates, or the actual or demonstrably anticipated research or development of the Company or its divisions or affiliates, or which result from any work performed by me for the Company or its divisions or affiliates, shall be promptly disclosed in writing by me to the Company.
6. I acknowledge that, except as provided in Paragraph 8 below, any computer software, applications, pictorial works, graphic works, sculptural works, related documentation and other works of authorship made, conceived or modified jointly or solely by me during my employment with the Company, or which result from tasks assigned to me by the Company, shall be considered “Works for Hire” under the copyright laws of the United States; and moreover, that all right, title and interest therein, including all rights of copyright, patent or otherwise, in the United States and in all foreign countries, in any form or medium and in all fields of use now known or hereafter existing, shall be exclusive property of the Company or its assignee.
7. Should an Invention, discovery, improvement or work of authorship not be deemed a Work for Hire for any reason, then, except as provided in Paragraph 8 below, I hereby irrevocably assign to the Company or its assignee, all of my right, title and interest in and to any such Inventions, discoveries, improvements or works of authorship. I further agree that the Company is under no further obligation, monetary or otherwise, to me for such assignment. I agree to execute, acknowledge and deliver to the Company, its successors and assigns, all documentation, including, but not limited to, applications for patents and/or copyrights, as the Company may reasonably deem necessary or desirable to obtain and perfect the interests of the Company, its successors and assigns, in any and all countries, but subject to the limitations in Paragraph 8 below, in such Inventions, discoveries, improvements and works of authorship and to vest title thereto in the Company.
Executive’s initials /s/ CC
2
8. I represent that all Inventions that I have developed before being employed by the Company (including its predecessors and subsidiaries), if any, are fully disclosed in the attached Memorandum of Inventions, Discoveries and Improvements Made Prior to Employment with the Company (the “Memorandum”). I understand I am not assigning any existing Inventions that I developed before being employed by the Company (including its predecessors and subsidiaries), which are disclosed in full in the attached Memorandum, and that any such Inventions are not subject to this Inventions Agreement.
9. For the avoidance of doubt, this Inventions Agreement does not prohibit or restrict me (or my attorney) from responding to any inquiry about the Inventions Agreement or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization or governmental entity, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. I understand and acknowledge that I do not need the prior authorization of the Company to make any such reports or disclosures and that I am not required to notify the Company that I have made such reports or disclosures.
10. Notwithstanding anything in this Inventions Agreement to the contrary, I understand that I may, without informing the Company prior to any such disclosure, disclose Confidential Information (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If I am compelled to disclose any Confidential Information by judicial or administrative process, I shall disclose only that portion of such information that I am advised by my counsel is legally required to be disclosed; provided, however, that I shall to the extent legally permissible provide the Company with advanced notice of the information that I intend to disclose as a result of such requirement and reasonably cooperate with the Company, at the Company’s sole cost and expense, in connection with the efforts of the Company to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information. Additionally, without informing the Company prior to any such disclosure, if I file a lawsuit against the Company for retaliation for reporting a suspected violation of law, I may disclose Confidential Information to my attorney and use the Confidential Information in the court proceeding or arbitration, provided that I file any document containing the Confidential Information under seal and do not otherwise disclose the Confidential Information, except pursuant to court order. Without prior authorization of the Company, however, I understand that the Company does not authorize me to disclose to any third party (including any government official or any attorney I may retain) any communications that are covered by the Company’s attorney-client privilege.
Executive’s initials /s/ CC
3
11. This Inventions Agreement shall be governed by the laws of the State of Illinois. The parties expressly agree that the state and federal courts of the State of Illinois will have exclusive jurisdiction of any controversy between me and the Company regarding this Inventions Agreement. Both parties expressly agree and acknowledge that no court action may be brought by either party to this Inventions Agreement outside the State of Illinois. However, in the event the parties have entered into an arbitration covenant, the jurisdiction of the controversy shall be governed by that understanding.
12. Failure of either party hereto to enforce any of the provisions of this Inventions Agreement, or any rights with respect thereto, shall in no way be considered to be a waiver of such provisions or rights or in any way affect the validity of this Inventions Agreement.
13. If any term, provision, covenant or condition of this Inventions Agreement is held by a court of competent jurisdiction or arbitrator if applicable to be invalid, void or unenforceable, the validity and enforceability of the remaining terms, provisions, covenants and conditions of this Inventions Agreement shall not in any way be affected, impaired or invalidated.
14. This Inventions Agreement shall be binding on my heirs, executors, legal representatives and assigns and shall inure to the benefit of any successors and assigns of the Company.
| /s/ XXXXXXXXXXX X. XXXXXXXXXX |
| Signature of Executive |
| Xxxxxxxxxxx X. Xxxxxxxxxx |
| Typewritten Name of Executive |
| President of USIS |
| Position or Title |
| November 13, 2018 |
| Date |
Executive’s initials /s/ CC
4
MEMORANDUM OF INVENTIONS, DISCOVERIES AND IMPROVEMENTS
MADE PRIOR TO EMPLOYMENT WITH TRANSUNION
| Date of Invention, Discovery or Improvement | Patent No. | Description of Invention, Discovery or Improvement | Individuals who Assisted in Creation/Development of Invention, Discovery or Improvement | |||
| Date: November 13, 2018 | Name: Xxxxxxxxxxx X. Xxxxxxxxxx |
Executive’s initials /s/ CC
5